elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38233183-2C3BDD4E-217D-4BDD-9D68-757C3475495C
Q38233183-2C3BDD4E-217D-4BDD-9D68-757C3475495C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38233183-2C3BDD4E-217D-4BDD-9D68-757C3475495C
Treating glioblastoma patients with poor performance status: where do we go from here?
P2860
Q38233183-2C3BDD4E-217D-4BDD-9D68-757C3475495C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38233183-2C3BDD4E-217D-4BDD-9D68-757C3475495C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f50f7c3e9ae8f000b9bb5f163db7d9556792135
P2860
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.